Novel substrates for, and sources of, progestogens for reproduction

Journal of Neuroendocrinology

Volumn 23, Issue 11, 2011, Pages 961-973

  Frye, Cheryl Anne ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Lordosis; Midbrain ventral tegmental area; Neurosteroid; Progesterone; Steroid biosynthesis; Steroid metabolism

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; GESTAGEN; NEUROSTEROID; PREGNANE X RECEPTOR; PROGESTERONE;

ANXIETY; BODY POSITION; EXPLORATORY BEHAVIOR; MATING; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SEXUAL FUNCTION; SOCIAL BEHAVIOR; STEROID METABOLISM; STEROIDOGENESIS; VENTRAL TEGMENTUM;

ANIMALS; FEMALE; MESENCEPHALON; NEUROTRANSMITTER AGENTS; PROGESTERONE; RECEPTORS, PROGESTERONE; REPRODUCTION; SEXUAL BEHAVIOR, ANIMAL; SIGNAL TRANSDUCTION; VENTRAL TEGMENTAL AREA;

EID: 80054765623     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2011.02180.x     Document Type: Review

References (178)

1. Baulieu EE. Steroid hormone receptors. Expos Annu Biochim Med 1980; 34: 1-25.
2. Baulieu EE. Neurosteroids: a new function in the brain. Biol Cell 1991; 71: 3-10.
3. Compagnone NA, Mellon SH. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol 2000; 21: 1-56.
4. Furukawa A, Miyatake A, Ohnishi T, Ichikawa Y. Steroidogenic acute regulatory protein (StAR) transcripts constitutively expressed in the adult rat central nervous system: colocalization of StAR, cytochrome P-450SCC (CYP XIA1), and 3β-hydroxysteroid dehydrogenase in the rat brain. J Neurochem 1998; 71: 2231-2238.
5. Majewska MD. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol 1992; 38: 379-395.
6. Mellon SH. Neurosteroids: biochemistry, modes of action, and clinical relevance. J Clin Endocrinol Metab 1994; 78: 1003-1008.
7. Paul SM, Purdy RH. Neuroactive steroids. FASEB J 1992; 6: 2311-2322.
8. Frye CA. Neurosteroids-from basic research to clinical perspectives. In: Rubin RT, Pfaff DW, eds. Hormones/Behavior Relations of Clinical Importance. San Diego, CA: Academic Press, 2009: 395-416.
9. Batarseh A, Papadopoulos V. Regulation of translocator protein 18kDa (TSPO) expression in health and disease states. Mol Cell Endocrinol 2010; 327: 1-12.
10. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 2006; 27: 402-409.
11. King SR, Matassa AA, White EK, Walsh LP, Jo Y, Rao RM, Stocco DM, Reyland ME. Oxysterols regulate expression of the steroidogenic acute regulatory protein. J Mol Endocrinol 2004; 32: 507-517.
12. Mellon SH, Deschepper CF. Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res 1993; 3: 283-292.
13. Papadopoulos V, Lecanu L, Brown RC, Han Z, Yao ZX. Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 2006; 138: 749-756.
14. Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Bäckman M, Ohlsson R, Postlind H, Blomquist P, Berkenstam A. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA 1998; 95: 12208-12213.
15. Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterström RH, Perlmann T, Lehmann JM. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998; 92: 73-82.
16. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 1998; 102: 1016-1023.
17. Frye CA. The role of neurosteroids and nongenomic effects of progestins in the ventral tegmental area in mediating sexual receptivity of rodents. Horm Behav 2001; 40: 226-233.
18. Frye CA. The role of neurosteroids and non-genomic effects of progestins and androgens in mediating sexual receptivity of rodents. Brain Res Brain Res Rev 2001; 37: 201-222.
19. Li X, Bertics PJ, Karavolas HJ. Regional distribution of cytosolic and particulate 5α-dihydroprogesterone 3α-hydroxysteroid oxidoreductases in female rat brain. J Steroid Biochem Mol Biol 1997; 60: 311-318.
20. Melcangi RC, Panzica G. Steroids and the nervous system. Introduction. Ann NY Acad Sci 2003; 1007: 1-5.
21. Beyer C, Hoffman KL, González-Flores O. Neuroendocrine regulation of estrous behavior in the rabbit: similarities and differences with the rat. Horm Behav 2007; 52: 2-11.
22. Etgen AM, Chu HP, Fiber JM, Karkanias GB, Morales JM. Hormonal integration of neurochemical and sensory signals governing female reproductive behavior. Behav Brain Res 1999; 105: 93-103.
23. Pfaff D, Frohlich J, Morgan M. Hormonal and genetic influences on arousal - sexual and otherwise. Trends Neurosci 2002; 25: 45-50.
24. Frye CA, Paris JJ. Progesterone turnover to its 5α-reduced metabolites in the ventral tegmental area of the midbrain is essential for initiating social and affective behavior and progesterone metabolism in female rats. J Endocrinol Invest 2011; 34: 188-199.
25. O'Malley BW. A life-long search for the molecular pathways of steroid hormone action. Mol Endocrinol 2005; 19: 1402-1411.
26. Pfaff DW, Gerlach JL, McEwen BS, Ferin M, Carmel P, Zimmerman EA. Autoradiographic localization of hormone-concentrating cells in the brain of the female rhesus monkey. J Comp Neurol 1976; 170: 279-293.
27. Pfaff DW, McEwen BS. Actions of estrogens and progestins on nerve cells. Science 1983; 219: 808-814.
28. O'Malley BW, Sherman MR, Toft DO. Progesterone 'receptors' in the cytoplasm and nucleus of chick oviduct target tissue. Proc Natl Acad Sci USA 1970; 67: 501-508.
29. Blaustein JD. Progestin receptors: neuronal integrators of hormonal and environmental stimulation. Ann NY Acad Sci 2003; 1007: 238-250.
30. Li X, Lonard DM, O'Malley BW. A contemporary understanding of progesterone receptor function. Mech Ageing Dev 2004; 125: 669-678.
31. Pratt WB. The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc Soc Exp Biol Med 1998; 217: 420-434.
32. Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med 2003; 228: 111-133.
33. Allan GF, Leng X, Tsai SY, Weigel NL, Edwards DP, Tsai MJ, O'Malley BW. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem 1992; 267: 19513-19520.
34. DeMarzo AM, Beck CA, Onate SA, Edwards DP. Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein. Proc Natl Acad Sci USA 1991; 88: 72-76.
35. Edwards DP, DeMarzo AM, Onate SA, Beck CA, Estes PA, Nordeen SK. Mechanisms controlling steroid receptor binding to specific DNA sequences. Steroids 1991; 56: 271-278.
36. Leonhardt SA, Boonyaratanakornkit V, Edwards DP. Progesterone receptor transcription and non-transcription signaling mechanisms. Steroids 2003; 68: 761-770.
37. Groshong SD, Owen GI, Grimison B, Schauer IE, Todd MC, Langan TA, Sclafani RA, Lange CA, Horwitz KB. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol Endocrinol 1997; 11: 1593-1607.
38. Richer JK, Lange CA, Manning NG, Owen G, Powell R, Horwitz KB. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity. J Biol Chem 1998; 273: 31317-31326.
39. Dressing GE, Goldberg JE, Charles NJ, Schwertfeger KL, Lange CA. Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications. Steroids 2011; 76: 11-17.
40. 5, but not progestin receptor, antagonist and anti-sense oligonucleotide infusions to the ventral tegmental area of cycling rats and hamsters attenuate lordosis. Behav Brain Res 1999; 103: 23-34.
41. Frye CA, Vongher JM. Progesterone and 3α, 5α-THP enhance sexual receptivity in mice. Behav Neurosci 2001; 115: 1118-1128.
42. Glaser JH, Etgen AM, Barfield RJ. Intrahypothalamic effects of progestin agonists on estrous behavior and progestin receptor binding. Physiol Behav 1985; 34: 871-877.
43. Mani SK, Blaustein JD, Allen JM, Law SW, O'Malley BW, Clark JH. Inhibition of rat sexual behavior by antisense oligonucleotides to the progesterone receptor. Endocrinology 1994; 135: 1409-1414.
44. Mani SK, Allen JM, Lydon JP, Mulac-Jericevic B, Blaustein JD, DeMayo FJ, Conneely O, O'Malley BW. Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice. Mol Endocrinol 1996; 10: 1728-1737.
45. Olster DH, Blaustein JD. Development of progesterone-facilitated lordosis in female guinea pigs: relationship to neural estrogen and progestin receptors. Brain Res 1989; 484: 68-76.
46. Ogawa S, Olazábal UE, Parhar IS, Pfaff DW. Effects of intrahypothalamic administration of antisense DNA for progesterone receptor mRNA on reproductive behavior and progesterone receptor immunoreactivity in female rat. J Neurosci 1994; 14: 1766-1774.
47. Pollio G, Xue P, Zanisi M, Nicolin A, Maggi A. Antisense oligonucleotide blocks progesterone-induced lordosis behavior in ovariectomized rats. Brain Res Mol Brain Res 1993; 19: 135-139.
48. Lange CA, Richer JK, Shen T, Horwitz KB. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways. J Biol Chem 1998; 273: 31308-31316.
49. Nilsen J, Brinton RD. Impact of progestins on estradiol potentiation of the glutamate calcium response. Neuroreport 2002; 13: 825-830.
50. Auger CJ, De Vries GJJ. Progestin receptor immunoreactivity within steroid-responsive vasopressin-immunoreactive cells in the male and female rat brain. Neuroendocrinology 2002; 14: 561-567.
51. Camacho-Arroyo I, Guerra-Araiza C, Cerbon MA. Progesterone receptor isoforms are differentially regulated by sex steroids in the rat forebrain. Neuroreport 1998; 9: 3993-3996.
52. Guerra-Araiza C, Cerbon MA, Morimoto S, Camacho-Arroyo I. Progesterone receptor isoforms expression pattern in the rat brain during the estrous cycle. Life Sci 2000; 66: 1743-1752.
53. Guerra-Araiza C, Reyna-Neyra A, Salazar AM, Cerbon MA, Morimoto S, Camacho-Arroyo I. Progesterone receptor isoforms expression in the prepuberal and adult male rat brain. Brain Res Bull 2001; 54: 13-17.
54. Guerra-Araiza C, Coyoy-Salgado A, Camacho-Arroyo I. Sex differences in the regulation of progesterone receptor isoforms expression in the rat brain. Brain Res Bull 2002; 59: 105-109.
55. Guerra-Araiza C, Villamar-Cruz O, Gonzalez-Arenas A, Chavira R, Camacho-Arroyo I. Changes in progesterone receptor isoforms content in the rat brain during the oestrous cycle and after oestradiol and progesterone treatments. J Neuroendocrinol 2003; 15: 984-990.
56. Hagihara K, Hirata S, Osada T, Hirai M, Kato J. Distribution of cells containing progesterone receptor mRNA in the female rat di- and telencephalon: an in situ hybridization study. Brain Res Mol Brain Res 1992; 14: 239-249.
57. Hagihara K, Hirata S, Osada T, Hirai M, Kato J. Expression of progesterone receptor in the neonatal rat brain cortex: detection of its mRNA using reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol 1992; 41: 637-640.
58. Kato J, Hirata S, Nozawa A, Mouri N. The ontogeny of gene expression of progestin receptors in the female rat brain. J Steroid Biochem Mol Biol 1993; 47: 173-182.
59. Kato J, Hirata S, Nozawa A, Yamada-Mouri N. Gene expression of progesterone receptor isoforms in the rat brain. Horm Behav 1994; 28: 454-463.
60. Brinton RD, Thompson RF, Foy MR, Baudry M, Wang J, Finch CE, Morgan TE, Pike CJ, Mack WJ, Stanczyk FZ, Nilsen J. Progesterone receptors: form and function in brain. Front Neuroendocrinol 2008; 29: 313-339.
61. Conneely OM, Maxwell BL, Toft DO, Schrader WT, O'Malley BW. The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA. Biochem Biophys Res Commun 1987; 149: 493-501.
62. Duffy DM, Wells TR, Haluska GJ, Stouffer RL. The ratio of progesterone receptor isoforms changes in the monkey corpus luteum during the luteal phase of the menstrual cycle. Biol Reprod 1997; 57: 693-699.
63. Kastner P, Bocquel MT, Turcotte B, Garnier JM, Horwitz KB, Chambon P, Gronemeyer HJ. Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptor isoforms. Biol Chem 1990; 265: 12163-12167.
64. Balasubramanian B, Portillo W, Reyna A, Chen JZ, Moore AN, Dash PK, Mani SK. Nonclassical mechanisms of progesterone action in the brain: II. Role of calmodulin-dependent protein kinase II in progesterone-mediated signaling in the hypothalamus of female rats. Endocrinology 2008; 149: 5518-5526.
65. Pietras R, Szego C. Endometrial cell calcium and oestrogen action. Nature 1975; 253: 357-359.
66. Norman A, Mizwicki M, Norman D. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 2004; 3: 27-41.
67. Thomas P. Characteristics of membrane progestin receptor α (mPRα) and progesterone membrane receptor component one (PGMRC1) and their roles in mediating rapid progestin actions. Front Neuroendocrinol 2008; 29: 292-312.
68. Zhu Y, Hanna R, Schaaf M, Spaink H, Thomas P. Candidates for membrane progestin receptors - past approaches and future challenges. Comp Biochem Physiol C Toxicol Pharmacol 2008; 148: 381-389.
69. Baldi E, Luconi M, Bonaccorsi L, Forti G. Nongenomic effects of progesterone on spermatozoa: mechanisms of signal transduction and clinical implications. Front Biosci 1998; 3: D1051-D1059.
70. Blackmore P, Beebe S, Danforth D, Alexander N. Progesterone and 17α-hydroxyprogesterone. Novel stimulators of calcium influx in human sperm. J Biol Chem 1990; 265: 1376-1380.
71. Luconi M, Francavilla F, Porazzi I, Macerola B, Forti G, Baldi E. Human spermatozoa as a model for studying membrane receptors mediating rapid nongenomic effects of progesterone and estrogens. Steroids 2004; 69: 553-559.
72. Maller JL. The elusive progesterone receptor in Xenopus oocytes. Proc Natl Acad Sci USA 2001; 98: 8-10.
73. Sabeur K, Edwards D, Meizel S. Human sperm plasma membrane progesterone receptor(s) and the acrosome reaction. Biol Reprod 1996; 54: 993-1001.
74. Thomas P, Tubbs C, Detweiler C, Das S, Ford L, Breckenridge-Miller D. Binding characteristics, hormonal regulation and identity of the sperm membrane progestin receptor in Atlantic croaker. Steroids 2005; 70: 427-433.
75. Josefsberg Ben-Yehoshua L, Lewellyn AL, Thomas P, Maller JL. The role of Xenopus membrane progesterone receptor β in mediating the effect of progesterone on oocyte maturation. Mol Endocrinol 2007; 21: 664-673.
76. 2+ and cyclic AMP during the first meiotic division in amphibian oocytes by progesterone. J Cyclic Nucleotide Res 1980; 6: 347-358.
77. Thomas P, Zhu Y, Pace M. Progestin membrane receptors involved in the meiotic maturation of teleost oocytes: a review with some new findings. Steroids 2002; 67: 511-517.
78. Calogero A, Palumbo M, Bosboom A, Burrello N, Ferrara E, Palumbo G, Petraglia F, D'Agata R. The neuroactive steroid allopregnanolone suppresses hypothalamic gonadotropin-releasing hormone release through a mechanism mediated by the gamma-aminobutyric acidA receptor. J Endocrinol 1998; 158: 121-125.
79. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986; 232: 1004-1007.
80. Sim J, Skynner M, Herbison A. Direct regulation of postnatal GnRH neurons by the progesterone derivative allopregnanolone in the mouse. Endocrinology 2001; 142: 4448-4453.
81. Faivre E, Skildum A, Pierson-Mullany L, Lange CA. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators. Steroids 2005; 70: 418-426.
82. Dosiou C, Hamilton A, Pang Y, Overgaard M, Tulac S, Dong J, Thomas P, Giudice L. Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J Endocrinol 2008; 196: 67-77.
83. Schwartz-Giblin S, Pfaff DW. Hypothalamic output controlling reticulospinal and vestibulospinal systems important for emotional behavior. Int J Neurol 19851986; 19-20: 89-110.
84. Blaustein JD, Tetel MJ, Ricciardi KH, Delville Y, Turcotte JC. Hypothalamic ovarian steroid hormone-sensitive neurons involved in female sexual behavior. Psychoneuroendocrinology 1994; 19: 505-516.
85. 125I-BSA] binding sites in the medial preoptic area and anterior hypothalamus. Brain Res 1995; 693: 225-232.
86. MacLusky NJ, McEwen BS. Progestin receptors in rat brain: distribution and properties of cytoplasmic progestin-binding sites. Endocrinology 1980; 106: 192-202.
87. 3H]R-5020 injection. Mol Cell Endocrinol 1978; 12: 67-79.
88. Frye CA, Murphy RE, Platek SM. Anti-sense oligonucleotides, for progestin receptors in the VMH and glutamic acid decarboxylase in the VTA, attenuate progesterone-induced lordosis in hamsters and rats. Behav Brain Res 2000; 115: 55-64.
89. Frye CA, Bayon LE, Vongher JM. Intravenous progesterone elicits a more rapid induction of lordosis in rats than does SKF38393. Psychobiology 2000; 28: 99-109.
90. Rose JD. Tectoreticular neuronal activity associated with behavior and progesterone action during the induction of lordosis responding in hamsters. Soc Neurosci Abstr 1990; 16: 924.
91. DeBold JF, Frye CA. Genomic and non-genomic actions of progesterone in the control of female hamster sexual behavior. Horm Behav 1994; 28: 445-453.
92. Pleim ET, Baumann J, Barfield RJ. A contributory role for midbrain progesterone in the facilitation of female sexual behavior in rats. Horm Behav 1991; 25: 19-28.
93. Frye CA, Mermelstein PG, DeBold JF. Evidence for a non-genomic action of progestins on sexual receptivity in hamster ventral tegmental area but not hypothalamus. Brain Res 1992; 578: 87-93.
94. Frye CA, Gardiner SG. Progestins can have a membrane-mediated action in rat midbrain for facilitation of sexual receptivity. Horm Behav 1996; 30: 682-691.
95. Frye CA. Progestins influence motivation, reward, conditioning, stress, and/or response to drugs of abuse. Pharmacol Biochem Behav 2007; 86: 209-219.
96. Frye CA, Rhodes ME, Petralia SM, Walf AA, Sumida K, Edinger KL. 3α-hydroxy-5α-pregnan-20-one in the midbrain ventral tegmental area mediates social, sexual, and affective behaviors. Neuroscience 2006; 138: 1007-1014.
97. Frye CA, Vongher JM. Progesterone has rapid and membrane effects in the facilitation of female mouse sexual behavior. Brain Res 1999; 815: 259-269.
98. Frye CA, Paris JJ. Effects of neurosteroid actions at N-methyl-D-aspartate and GABA A receptors in the midbrain ventral tegmental area for anxiety-like and mating behavior of female rats. Psychopharmacology 2011; 213: 93-103.
99. Petralia SM, DeBold JF, Frye CA. MK-801 infusions to the ventral tegmental area and ventromedial hypothalamus produce opposite effects on lordosis of hormone-primed rats. Pharmacol Biochem Behav 2007; 86: 377-385.
100. Frye CA, Marrone J, Walf A. Effects of manipulating progesterone and NMDA receptors in the ventral tegmental area for lordosis of hamsters and rats. Psychopharmacology 2008; 200: 71-80.
101. Rupprecht R, Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 1999; 22: 410-416.
102. Johannessen M, Fontanilla D, Mavlyutov T, Ruoho AE, Jackson MB. Antagonist action of progesterone at σ-receptors in the modulation of voltage-gated sodium channels. Am J Physiol Cell Physiol 2011; 300: C328-C337.
103. Frye CA, Walf AA. Oxytocin and/or steroid hormone binding globulin infused into the ventral tegmental area modulates progestogen-mediated lordosis. Neuropharmacology 2010; 58: 44-49.
104. Chaban VV, Lakhter AJ, Micevych P. A membrane estrogen receptor mediates intracellular calcium release in astrocytes. Endocrinology 2004; 145: 3788-3795.
105. Zhu Y, Bond J, Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 2003; 100: 2237-2242.
106. Mascó D, Weigel R, Carrer HF. Gamma aminobutyric acid mediates ventromedial hypothalamic mechanisms controlling the execution of lordotic responses in the female rat. Behav Brain Res 1986; 19: 153-162.
107. Westerling P, Lindgren S, Meyerson B. Functional changes in GABAA receptor stimulation during the oestrous cycle of the rat. Br J Pharmacol 1991; 103: 1580-1584.
108. Wilson MA. Influences of gender, gonadectomy, and estrous cycle on GABA/BZ receptors and benzodiazepine responses in rats. Brain Res Bull 1992; 29: 165-172.
109. Frye CA. Inhibition of 5α-reductase enzyme or GABA(A) receptors in the VMH and the VTA attenuates progesterone-induced sexual behavior in rats and hamsters. J Endocrinol Invest 2001; 24: 399-407.
110. Frye CA, DeBold JF. Muscimol facilitates sexual receptivity in hamsters when infused into the ventral tegmentum. Pharmacol Biochem Behav 1992; 42: 879-887.
111. Frye CA, Mermelstein PG, DeBold JF. Bicuculline infused into the hamster ventral tegmentum inhibits, while sodium valproate facilitates, sexual receptivity. Pharmacol Biochem Behav 1993; 46: 1-8.
112. A receptors. Horm Behav 2006; 50: 332-337.
113. Frye CA, Vongher JM. Progestins' rapid facilitation of lordosis when applied to the ventral tegmentum corresponds to efficacy at enhancing GABAA receptor activity. J Neuroendocrinol 1999; 11: 829-837.
114. Harrison NL, Majewska MD, Harrington JW, Barker JL. Structure-activity relationships for steroid interaction with the gamma-aminobutyric acidA receptor complex. J Pharmacol Exp Ther 1987; 241: 346-353.
115. Belelli D, Lambert JJ. Neurosteroids: endogenous regulators of the GABA(a) receptor. Nat Rev Neurosci 2005; 6: 565-575.
116. Brot MD, Akwa Y, Purdy RH, Koob GF, Britton KT. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. Eur J Pharmacol 1997; 325: 1-7.
117. Gee KW, McCauley LD, Lan NC. A putative receptor for neurosteroids on the GABAA receptor complex: the pharmacological properties and therapeutic potential of epalons. Crit Rev Neurobiol 1995; 9: 207-227.
118. A receptors. Prog Neurobiol 2003; 71: 67-80.
119. Morrow AL, Suzdak PD, Paul SM. Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur J Pharmacol 1987; 142: 483-485.
120. Reddy DS. Pharmacology of catamenial epilepsy. Methods Find Exp Clin Pharmacol 2004; 26: 547-561.
121. Weir CJ, Ling AT, Belelli D, Wildsmith JA, Peters JA, Lambert JJ. The interaction of anaesthetic steroids with recombinant glycine and GABAA receptors. Br J Anaesth 2004; 92: 704-711.
122. Vincens M, Shu C, Moguilewsky M, Philibert D. A progesterone metabolite enhances the activity of the GABAA receptor complex at the pituitary level. Eur J Pharmacol 1989; 168: 15-21.
123. Im WB, Blakeman DP, Davis JP. Na(+)-dependent GABA transport system scavenges endogenous external GABA and prevents desensitization of GABAA receptors in rat cerebrocortical synaptoneurosomes. Brain Res 1990; 521: 143-147.
124. Steffensen SC, Svingos AL, Pickel VM, Henriksen SJ. Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J Neurosci 1998; 18: 8003-8015.
125. Mansvelder HD, De Rover M, McGehee DS, Brussaard AB. Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction. Eur J Pharmacol 2003; 480: 117-123.
126. Bayer VE, Pickel VM. GABA-labeled terminals form proportionally more synapses with dopaminergic neurons containing low densities of tyrosine hydroxylase immunoreactivity in rat ventral tegmental area. Brain Res 1991; 559: 44-55.
127. Willick ML, Kokkinidis L. The effects of ventral tegmental administration of GABAA, GABAB and NMDA receptor agonists on medial forebrain bundle self-stimulation. Behav Brain Res 1995; 70: 31-36.
128. Park-Chung M, Wu FS, Farb DH. α-Hydroxy-5α-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons. Mol Pharmacol 1994; 46: 146-150.
129. Cyr M, Ghribi O, Di Paolo T. Regional and selective effects of oestradiol and progesterone on NMDA and AMPA receptors in the rat brain. J Neuroendocrinol 2000; 12: 445-452.
130. Wu FS, Gibbs TT, Farb DH. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol Pharmacol 1991; 40: 333-336.
131. Stoof JC, Kebabian JW. Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci 1984; 35: 2281-2296.
132. Churchill L, Dilts RP, Kalivas PW. Autoradiographic localization of gamma-aminobutyric acidA receptors within the ventral tegmental area. Neurochem Res 1992; 17: 101-106.
133. Klitenick MA, DeWitte P, Kalivas PW. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci 1992; 12: 2623-2632.
134. Lévesque D, Di Paolo T. Effect of the rat estrous cycle at ovariectomy on striatal D-1 dopamine receptors. Brain Res Bull 1990; 24: 281-284.
135. Frye CA, Walf AA, Sumida K. Progestins' actions in the VTA to facilitate lordosis involve dopamine-like Type 1 and 2 receptors. Pharmacol Biochem Behav 2004; 78: 405-418.
136. Sumida K, Walf AA, Frye CA. Progestin-facilitated lordosis of hamsters may involve dopamine-like type 1 receptors in the ventral tegmental area. Behav Brain Res 2005; 161: 1-7.
137. Feng XQ, Dong Y, Fu YM, Zhu YH, Sun JL, Wang Z, Sun FY, Zheng P. Progesterone inhibition of dopamine-induced increase in frequency of spontaneous excitatory postsynaptic currents in rat prelimbic cortical neurons. Neuropharmacology 2004; 46: 211-222.
138. A receptors involve downstream signal transduction pathways. Steroids 2008; 73: 906-913.
139. Kow LM, Pfaff DW. Mapping of neural and signal transduction pathways for lordosis in the search for estrogen actions on the central nervous system. Behav Brain Res 1998; 92: 169-180.
140. Girault JA, Greengard P. The neurobiology of dopamine signaling. Arch Neurol 2004; 61: 641-644.
141. Fáncsik A, Linn DM, Tasker JG. Neurosteroid modulation of GABA IPSCs is phosphorylation dependent. J Neurosci 2000; 20: 067-075.
142. 1 and GABA(A) receptors in the ventral tegmental area may be G-protein-dependent. Behav Brain Res 2006; 172: 286-293.
143. Frye CA, Walf AA. In the ventral tegmental area, the membrane-mediated actions of progestins for lordosis of hormone-primed hamsters involve phospholipase C and protein kinase C. J Neuroendocrinol 2007; 19: 717-724.
144. Frye CA, Walf AA, Petralia SM. Progestin facilitation of lordosis in rodents involves adenylyl cyclase activity in the ventral tegmental area. Horm Behav 2006; 50: 237-244.
145. Frye CA, Walf AA. In the ventral tegmental area, progestogens' membrane-mediated actions for lordosis of rats involve the second-messenger phospholipase C. Brain Res 2008; 1230: 218-223.
146. Frye CA, Walf AA. Activity of protein kinase C is important for 3α, 5α-THP's actions at dopamine type 1-like and/or GABAA receptors in the ventral tegmental area for lordosis of rats. Brain Res Bull 2008; 77: 91-97.
147. Frye CA, Walf AA. Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone- and a dopamine type 1-like receptor agonist to facilitate lordosis. Behav Brain Res 2010; 206: 286-292.
148. Petralia SM, Frye CA. In the ventral tegmental area, cyclic AMP mediates the actions of progesterone at dopamine type 1 receptors for lordosis of rats and hamsters. J Neuroendocrinol 2006; 18: 902-914.
149. Petralia SM, Frye CA. In the ventral tegmental area, G-proteins and cAMP mediate the neurosteroid 3α, 5α-THP's actions at dopamine type 1 receptors for lordosis of rats. Neuroendocrinology 2004; 80: 233-243.
150. Petralia SM, Walf AA, Frye CA. In the ventral tegmental area, progestins' membrane-mediated actions for lordosis of hamsters and rats involve protein kinase A. Neuroendocrinology 2006; 84: 405-414.
151. Frye CA, Rhodes ME. Progestin concentrations are increased following paced mating in midbrain, hippocampus, diencephalon, and cortex of rats in behavioral estrus, but only in midbrain of diestrous rats. Neuroendocrinology 2006; 83: 336-347.
152. Frye CA, Sumida K, Zimmerberg B, Brunelli SA. Rats bred for high versus low anxiety responses neonatally demonstrate increases in lordosis, pacing behavior, and midbrain 3α, 5α-THP levels as adults. Behav Neurosci 2006; 120: 281-289.
153. Frye CA, Paris JJ, Rhodes ME. Engaging in paced mating, but neither exploratory, anti-anxiety, nor social behavior, increases 5α-reduced progestin concentrations in midbrain, hippocampus, striatum, and cortex. Reproduction 2007; 133: 663-674.
154. Walf AA, Paris JJ, Llaneza DC, Frye CA. I. Levels of 5α-reduced progesterone metabolite in the midbrain account for variability in reproductive behavior of middle-aged female rats. Brain Res 2011; 1379: 137-148.
155. Frye CA, Leadbetter EA. 5α-reduced progesterone metabolites are essential in hamster VTA for sexual receptivity. Life Sci 1994; 54: 653-659.
156. Frye CA, Petralia SM. Lordosis of rats is modified by neurosteroidogenic effects of membrane benzodiazepine receptors in the ventral tegmental area. Neuroendocrinology 2003; 77: 71-82.
157. Petralia SM, Jahagirdar V, Frye CA. Inhibiting biosynthesis and/or metabolism of progestins in the ventral tegmental area attenuates lordosis of rats in behavioural oestrus. J Neuroendocrinol 2005; 17: 545-552.
158. Frye CA, Bayon LE, Pursnani NK, Purdy RH. The neurosteroids, progesterone and 3α, 5α-THP, enhance sexual motivation, receptivity, and proceptivity in female rats. Brain Res 1998; 808: 72-83.
159. Dong E, Matsumoto K, Uzunova V, Sugaya I, Takahata H, Nomura H, Watanabe H, Costa E, Guidotti A. Brain 5α-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc Natl Acad Sci USA 2001; 98: 2849-2854.
160. Matsumoto K, Pinna G, Puia G, Guidotti A, Costa E. Social isolation stress-induced aggression in mice: a model to study the pharmacology of neurosteroidogenesis. Stress 2005; 8: 85-93.
161. Pinna G, Dong E, Matsumoto K, Costa E, Guidotti A. In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proc Natl Acad Sci USA 2003; 100: 2035-2040.
162. A receptors, and escalated aggressive behavior. Horm Behav 2003; 44: 242-257.
163. Fish EW, Faccidomo S, DeBold JF, Miczek KA. Alcohol, allopregnanolone and aggression in mice. Psychopharmacology 2001; 153: 473-483.
164. Frye CA, Rhodes ME, Walf A, Harney JP. Testosterone enhances aggression of wild-type mice but not those deficient in type I 5alpha-reductase. Brain Res 2002; 948: 165-170.
165. Pinna G, Agis-Balboa RC, Pibiri F, Nelson M, Guidotti A, Costa E. Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice. Neurochem Res 2008; 33: 1990-2007.
166. Frye CA, Petralia SM, Rhodes ME. Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3a, 5a-THP. Pharmacol Biochem Behav 2000; 67: 587-596.
167. Frye CA, Walf AA. Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav 2002; 41: 306-315.
168. Rhodes ME, Frye CA. Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors. Cogn Affect Behav Neurosci 2001; 1: 287-296.
169. Frye CA, Paris JJ, Rhodes ME. Increasing 3α, 5α-THP following inhibition of neurosteroid biosynthesis in the ventral tegmental area reinstates anti-anxiety, social, and sexual behavior of naturally receptive rats. Reproduction 2009; 137(1): 119-128.
170. Frye CA, Rhodes ME. Infusions of 5α-pregnan-3α-ol-20-one (3α, 5α-THP) to the ventral tegmental area, but not the substantianigra, enhance exploratory, anti-anxiety, social and sexual behaviours and concomitantly increase 3α, 5α-THP concentrations in the hippocampus, diencephalon and cortex of ovariectomised oestrogen-primed rats. J Neuroendocrinol 2006; 18: 960-975.
171. Frye CA, Rhodes ME. Infusions of 3α, 5α-THP to the VTA enhance exploratory, anti-anxiety, social, and sexual behavior and increase levels of 3α, 5α-THP in midbrain, hippocampus, diencephalon, and cortex of female rats. Behav Brain Res 2008; 187: 88-99.
172. Xu C, Li CY, Kong AN. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 2005; 28: 249-268.
173. Woods CG, Heuvel JP, Rusyn I. Genomic profiling in nuclear receptor-mediated toxicity. Toxicol Pathol 2007; 35: 474-494.
174. Harmsen S, Meijerman I, Beijnen J, Schellens JH. The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology. Cancer Treat Rev 2007; 33: 369-380.
175. Masuyama H, Suwaki N, Tateishi Y, Nakatsukasa H, Segawa T, Hiramatsu Y. The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion. Mol Endocrinol 2005; 19: 1170-1180.
176. Marini S, Nannelli A, Sodini D, Dragoni S, Valoti M, Longo V, Gervasi PG. Expression, microsomal and mitochondrial activities of cytochrome P450 enzymes in brain regions from control and phenobarbital-treated rabbits. Life Sci 2007; 13: 910-917.
177. Bauer B, Hartz AM, Fricker G, Miller DS. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol 2004; 66: 413-419.
178. Lamba V, Yasuda K, Lamba JK, Assem M, Davila J, Strom S, Schuetz EG. PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol Appl Pharmacol 2004; 199: 251-265.